References
- Quoix E., Fraser R., Wolkove N., et al. Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer 1990; 66: 577–82
- Sorensen J. B. Endobronchial metastases from extrapulmonary solid tumors. Acta Oncologica 2004; 43: 73–9
- Ma P. C., Blaszkowsky L., Bharti A., et al. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer. Anticancer Res 2003; 23: 49–62
- Singletary S. E., Walsh G., Vauthey J. N., et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 2003; 8: 241–51
- Charalabopoulos K., Dalavaga Y., Stefanou D., et al. Direct endobronchial metastasis is a rare metastatic pattern in breast cancer. Int J Clin Pract 2004; 58: 641–4
- Nesland J. M., Holm R., Johannessen J. V., et al. Neuroendocrine differentiation in breast lesions. Pathol Res Pract 1988; 183: 214–21
- Nouman G. S., Anderson J. J., Crosier S., et al. Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast. J Clin Pathol 2003; 56: 507–11
- Kaiser U., Hofmann J., Schilli M., et al. Steroid‐hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 1996; 67: 357–64
- Uccini S., Monardo F., Paradiso P., et al. Synaptophysin in human breast carcinomas. Histopathology 1991; 18: 271–3
- Bofin A. M., Qvigstad G., Waldum C., et al. Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A‐positive tumour cells in more breast tumours than previously realized. APMIS 2002; 110: 658–64
- Gosney J. R., Gosney M. A., Lye M., et al. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma. Thorax 1995; 50: 116–20
- Harlamert H. A., Mira J., Bejarano P. A., et al. Thyroid transcription factor‐1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol 1998; 42: 1382–8